Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with MAZE: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
MAZE
Maze Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
MAZE
Maze Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MAZE: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
MAZE, dashed
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.50
· delayed
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
MAZE
Maze Therapeutics, Inc.
Change
34.20
▲
+5.13%
· post 34.22
· delayed
After hours
Nov 6 '26
delayed
Mkt cap
$1.9B
Revenue
$20M
Q1 FY26
Revenue
—
vs
Compare
After hours
Nov 6 '26
delayed
AMGN
Amgen Inc
vs
MAZE
Maze Therapeutics, Inc.
460.55
▲
+0.06%
post 460.50
delayed
Price
34.20
▲
+5.13%
post 34.22
delayed
$249.0B
Mkt cap
$1.9B
Q3 FY26
$10.4B
Revenue
$20M
Q1 FY26
FY25
$36.8B
Revenue
—
Change
Change
AMGN
460.55
▲
+0.06%
vs
MAZE
34.20
▲
+5.13%
After hours
Nov 6 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only MAZE
4
NBIX
Neurocrine Biosciences
customer
—
Shionogi
unlisted
customer
—
Trace Neuroscience
unlisted
customer
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Alloy Therapeutics
unlisted
customer